March 2, 2025 - 02:17

A recent study published in Clinical Diabetes highlights the potential of new diabetes technology to improve health outcomes for individuals with type 1 diabetes. Researchers from the University of Colorado Anschutz Medical Campus and Massachusetts General Hospital have found that when trained by a primary care provider or through telehealth, patients can effectively utilize the iLet Bionic Pancreas system. This technology, which was previously only examined in specialized endocrinology settings, shows promise in broadening access to care for those who may have difficulty visiting a specialist.
The findings suggest that integrating advanced diabetes management tools into primary care can empower patients to manage their condition more effectively. This approach not only enhances the quality of care but also addresses barriers faced by many individuals in accessing specialized diabetes treatment. By leveraging telehealth and training from primary care providers, the iLet Bionic Pancreas system could become a vital resource in improving the lives of those living with type 1 diabetes.
May 25, 2026 - 23:35
Pope calls for AI regulation, using technology for common good rather than profitPope Leo XIV issued a powerful call for global regulation of artificial intelligence on Monday, urging developers and governments to prioritize the common good over corporate profits. In a...
May 25, 2026 - 07:17
ANT Systems Launches Industrial-Scale Production of Drought Technology Used on Five ContinentsISTANBUL, Türkiye -- Agricultural nano-technology company ANT Systems has announced the start of industrial-scale production of NANOTERN, a biodegradable water-retention material made from...
May 24, 2026 - 23:42
POET Technologies: Great Technology, Terrible InvestmentPOET Technologies, once a high-flying name in the photonics space, has been handed a Sell rating by analysts who see little near-term payoff for investors. The core issue is a stark mismatch...
May 24, 2026 - 04:15
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the BunchThe first quarter earnings season has now drawn to a close for the healthcare technology for providers sector, and the results paint a clear picture of which companies are thriving and which are...